Peripheral Artery Disease

Healio and Cardiology Today have compiled a list of the top cardiology news from the month of May.

Results from a trial published in JAMA demonstrated that medication reduction is feasible in older patients receiving multiple hypertensive treatments for BP control. This was the top story in cardiology last week.

In observance of May being American Stroke Month, Healio and Cardiology Today have compiled a list of top recent updates in stroke research.

This year, the American College of Cardiology Scientific Session was, for the first time, held virtually. Here are some of the highlights selected by experts interviewed by Healio.

People with an adverse childhood family environment had elevated risk for CVD and all-cause mortality at middle age, according to a study published in the Journal of the American Heart Association.

Higher alcohol consumption predicted by genetics was associated with elevated risk for peripheral artery disease and stroke, according to a study published in Circulation: Genomic and Precision Medicine.

Adults who reported job strain had an increased risk of hospitalization for peripheral artery disease, according to a study published in the Journal of the American Heart Association.

Triglyceride-rich lipoprotein cholesterol was strongly linked to future peripheral artery disease and MI events in women, according to a study published in the Journal of the American College of Cardiology.

Low-dose rivaroxaban (Xarelto, Bayer/Janssen) twice daily plus aspirin vs. placebo plus aspirin in PAD.

In the VOYAGER PAD trial, patients with symptomatic peripheral artery disease who underwent lower-extremity revascularization had a lower incidence of major adverse limb and CV events compared if treated with low-dose rivaroxaban twice daily plus aspirin, compared with aspirin only.